Hemostasis, the body’s normal physiological response to prevent bleeding after a vascular injury, is a key procedure within the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is significant for the survival of a patient, making haemostasis the main target of widespread research and study. Due to the critical nature of the procedure, the marketplace for haemostasis products has gained a prominent position within the field of drugs and healthcare.
The global Hemostasis/Coagulation Analyzer Market Expected to Exceed more than US$ 5.90 Billion by 2028 at a CAGR 5.8%.
The increasing global prevalence of haemophilia A and B, the foremost common inherited bleeding disorders, a big surge during a sort of surgeries and trauma patients, and therefore the rising use of recombinant products are collectively driving the international haemostasis market. The rapid rate of introduction of cost effective and biodegradable products within the global market is additionally aiding the expansion of the market. Growth across cost-sensitive emerging markets is being essentially a product of the straightforward availability of cost-effective products. Nevertheless, the vast saturation within the global haemostasis market and high cost structures of advanced haemostasis product varieties are hampering the expansion of the market.
The global Hemostasis/Coagulation Analyzer market is segregated on the basis of Product as Clinical Laboratory Analysers and Analysers for Point-of-Care Testing. Based on Test the global Hemostasis/Coagulation Analyzer market is segmented in Prothrombin Time, Fibrinogen, Activated Partial Thromboplastin Time, Activated Clotting Time, D Dimer, Platelet Function, Anti-factor Xa, Heparin & Protamine Dose Response Test for ACT, and Other Coagulation Tests.
Based on Technology, the global Hemostasis/Coagulation Analyzer market is segmented in Mechanical, Optical, Electrochemical, and Other Technologies. The report also bifurcates the global Hemostasis/Coagulation Analyzer market based on End User in Clinical Laboratories, POC, and Others End Users.
The global Hemostasis/Coagulation Analyzer market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Hemostasis/Coagulation Analyzer market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Siemens AG, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., Sysmex Corporation, Nihon Kohden Corporation, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory, International Technidyne Corporation, and others are among the major players in the global Hemostasis/Coagulation Analyzer market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Hemostasis/Coagulation Analyzer Market has been segmented as below:
Hemostasis/Coagulation Analyzer Market, By Product
Hemostasis/Coagulation Analyzer Market, By Test
Hemostasis/Coagulation Analyzer Market, By Technology
Hemostasis/Coagulation Analyzer Market, By End User
Hemostasis/Coagulation Analyzer Market, By Region
Hemostasis/Coagulation Analyzer Market, By Company
The report covers:
Report Scope:
The global Hemostasis/Coagulation Analyzer market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics.
The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Hemostasis/Coagulation Analyzer market share. Major industry players with significant revenue share include Siemens AG, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., Sysmex Corporation, Nihon Kohden Corporation, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory, International Technidyne Corporation, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Hemostasis/Coagulation Analyzer Market, By Product
5.1 Introduction
5.2 Clinical Laboratory Analysers
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Analysers for Point-of-Care Testing
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Hemostasis/Coagulation Analyzer Market, By Test
6.1 Introduction
6.2 Prothrombin Time
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Fibrinogen
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Activated Partial Thromboplastin Time
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Activated Clotting Time
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 D Dimer
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Platelet Function
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Anti-factor Xa
6.8.1 Market Overview
6.8.2 Market Size and Forecast
6.9 Heparin & Protamine Dose Response Test for ACT
6.9.1 Market Overview
6.9.2 Market Size and Forecast
6.10 Other Coagulation Tests
6.10.1 Market Overview
6.10.2 Market Size and Forecast
7. Hemostasis/Coagulation Analyzer Market, By Technology
7.1 Introduction
7.2 Mechanical
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Optical
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Electrochemical
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other Technologies
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Hemostasis/Coagulation Analyzer Market, By End User
8.1 Introduction
8.2 Clinical Laboratories
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 POC
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Others End Users
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9. Hemostasis/Coagulation Analyzer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Hemostasis/Coagulation Analyzer, By Product
9.2.2 North America Hemostasis/Coagulation Analyzer, By Test
9.2.3 North America Hemostasis/Coagulation Analyzer, By Technology
9.2.4 North America Hemostasis/Coagulation Analyzer, By End User
9.3 Europe
9.3.1 Europe Hemostasis/Coagulation Analyzer, By Product
9.3.2 Europe Hemostasis/Coagulation Analyzer, By Test
9.3.3 Europe Hemostasis/Coagulation Analyzer, By Technology
9.3.4 Europe Hemostasis/Coagulation Analyzer, By End User
9.4 Asia-Pacific
9.4.1 Asia-Pacific Hemostasis/Coagulation Analyzer, By Product
9.4.2 Asia-Pacific Hemostasis/Coagulation Analyzer, By Test
9.4.3 Asia-Pacific Hemostasis/Coagulation Analyzer, By Technology
9.4.4 Asia-Pacific Hemostasis/Coagulation Analyzer, By End User
9.5 Rest of the World
9.5.1 Rest of the World Hemostasis/Coagulation Analyzer, By Product
9.5.2 Rest of the World Hemostasis/Coagulation Analyzer, By Test
9.5.3 Rest of the World Hemostasis/Coagulation Analyzer, By Technology
9.5.4 Rest of the World Hemostasis/Coagulation Analyzer, By End User
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
11.1 Siemens AG
11.2 Thermo Fisher Scientific Inc.
11.3 Roche Diagnostics
11.4 Alere Inc.
11.5 Sysmex Corporation
11.6 Nihon Kohden Corporation
11.7 Diagnostica Stago
11.8 Helena Laboratories
11.9 Instrumentation Laboratory
11.10 International Technidyne Corporation
11.11 Abbott Laboratories, Inc.
11.12 BARD, A Becton, Dickinson Company
11.13 Baxter International, Inc.
11.14 CSL Behring
11.15 Grifols SA
11.16 Integra Life Sciences Corporation
11.17 Johnson & Johnson
11.18 Medtronic PLC
11.19 Pfizer, Inc
The Hemostasis/Coagulation Analyzer Market has been segmented as below:
Hemostasis/Coagulation Analyzer Market, By Product
Hemostasis/Coagulation Analyzer Market, By Test
Hemostasis/Coagulation Analyzer Market, By Technology
Hemostasis/Coagulation Analyzer Market, By End User
Hemostasis/Coagulation Analyzer Market, By Region
Hemostasis/Coagulation Analyzer Market, By Company
